Concepedia

Jane A. Thanassi

JA

29

Publications

1.5K

Citations

23

H-Index

1992

Active since

Affiliations

Achillion Pharmaceuticals (United States)(Current)

Bristol-Myers Squibb (United States)

Virginia Commonwealth University Medical Center

Johns Hopkins University

Johns Hopkins Medicine

Jane A. Thanassi is an author at Achillion Pharmaceuticals (United States) specializing in medicine, microbiology, and antimicrobial resistance.

Top concepts

Publications per year

1992–2022

29

Publications

29

Identification of 113 conserved essential genes using a high-throughput gene disruption system in Streptococcus pneumoniae

Jane A. Thanassi · Nucleic Acids Research · 2002 · 229 citations · Full text

, , +19

Dissemination among staphylococci of DNA sequences associated with methicillin resistance

Gordon L. Archer, Debra M. Niemeyer, Jane A. Thanassi et al. · Antimicrobial Agents and Chemotherapy · 1994 · 151 citations · Full text

, , +16

Role of mecA transcriptional regulation in the phenotypic expression of methicillin resistance in Staphylococcus aureus

Debra M. Niemeyer, Michael J. Pucci, Jane A. Thanassi et al. · Journal of Bacteriology · 1996 · 113 citations · Full text

, , +22

Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome

Xuan Yuan, Eleni Gavriilaki, Jane A. Thanassi et al. · Haematologica · 2016 · 98 citations · Full text

Characterization of IS1272, an insertion sequence-like element from Staphylococcus haemolyticus

Gordon L. Archer, Jane A. Thanassi, Debra M. Niemeyer et al. · Antimicrobial Agents and Chemotherapy · 1996 · 69 citations · Full text

, , +22

Rows per page

1–5 of 29